Patient Recruitment Featured Articles
-
Should We Be Paying Clinical Research Participants? A Global Perspective
3/4/2025
Eduardo F. Motti, MD discusses patient payment from a global perspective, arguing that patient payment isn't thought of the same way around the world as it is in the U.S.
-
Understanding Lupus Trial Participation And The Importance Of Patient Support
2/27/2025
Lupus Therapeutics Director of Patient Engagement Caroline Donovan explores the challenges of patient enrollment and heralds the role of patient support in running successful trials for lupus patients.
-
Out Of The (Black) Box Thinking For Patient Recruitment
2/20/2025
In the fourth article in his series “Inspired Patient Recruitment — Taking Inspiration from Business Advice Bestsellers," Ross Jackson applies the concept of meticulous analysis from "Black Box Thinking" to clinical trial patient recruitment.
-
Want More Candidates For Rare Disease Trials? Turn To Genetic Testing
2/18/2025
Discover the value genetic testing can provide to rare disease patient recruitment efforts with insights from primary immunodeficiencies and immune dysregulation expert Jolan Eszter Walter, MD, Ph.D.
-
The Scoop On SCOPE
2/7/2025
Chief Editor Dan Schell summarizes some of his favorite quotes and learnings from the 2025 SCOPE Summit. Spoiler alert … Not everything is about AI these days.
-
Annual SCOPE Summit Serves Up A Similar But Satisfying Menu
2/7/2025
Executive editor Abby Proch sums up her second SCOPE Summit experience.
-
How "Atomic Habits" Can Help Optimize Patient Recruitment
1/31/2025
With the third article in his series “Inspired Patient Recruitment — Taking Inspiration from Business Advice Bestsellers," Ross Jackson applies theories from "Atomic Habits" by James Clear to clinical trial patient recruitment.
-
FDA Issues Draft Guidance: Study Of Sex Differences In The Clinical Evaluation Of Medical Products
1/29/2025
The U.S. FDA's recent draft guidance on the Study of Sex Differences in the Clinical Evaluation of Medical Products deduces that individuals whose sex is assigned as “female” at birth are underrepresented in clinical trials. The public comment period ends April 7 (in theory), though it should be noted that the guidance was removed from the FDA website shortly after the new administration took office.
-
We're Looking At Patient Recruitment All Wrong
1/22/2025
Leanne Woehlke, a 30-year veteran of the clinical research industry, says our standard patient recruitment efforts are lacking one key element — a focus on the patient’s needs.
-
What Does It Mean To Be "Underserved"?
1/8/2025
Learn what makes someone "underserved," understand the importance of that person's participation in research, learn about the barriers to them doing so, and discover ways to improve their inclusion.